Biotech
Incyte
Incyte raises $25B Public at $28B valuation
1801 Augustine Cut-Off, Wilmington, DE 19803January 1, 20241 min read
Total Raised
$25B
Valuation
$28B
Latest Round
Public
Employees
2500+
Incyte: Public Funding Round
Incyte has successfully raised $25B in Public funding, reaching a valuation of $28B.
Company Overview
Biopharmaceutical company
Funding Details
The Public round was led by Public.
Company Information
- Headquarters: 1801 Augustine Cut-Off, Wilmington, DE 19803
- Founded: 1991
- Employees: 2500+
- Category: Biotech
Investment
Incyte plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public: Verified investor in Public
Company Info
Headquarters
1801 Augustine Cut-Off, Wilmington, DE 19803
Founded
1991
Team Size
2500+
Last Round
$25B(Jan 2024)
Investors (1)
P
PublicLeadLead Investor
Verified investor in Public
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free